According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market demand would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for Post-Traumatic Stress Disorder (PTSD) Treatment is expected to reach US$ 27.37 billion. The market’s growth might be attributed to the increased prevalence of PTSD globally.
According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable.
Get a Sample Copy of the Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16801
In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potential results in reducing PTSD symptoms by allowing clients to address their trauma in a secure and controlled environment. Limbix and Psious, for example, are developing VRET platforms to treat PTSD and other mental health problems.
Key Takeaways from the Market Study
- The market for Post-Traumatic Stress Disorder (PTSD) Treatment is predicted to increase at a 5% CAGR from 2023 to 2033.
- Antidepressants are predicted to hold 41% of the market share for Post-Traumatic Stress Disorder (PTSD) Treatment in 2023.
- In 2023, North America is estimated to have 43% of the market for Post-Traumatic Stress Disorder (PTSD) Treatment.
- In 2023, Europe’s Post-Traumatic Stress Disorder (PTSD) Treatment market is estimated to account for 42% of the total.
“As the prevalence of PTSD continues to rise, the need for effective and accessible treatments will only become more pressing. While there is still much work to be done, the growing focus on PTSD treatment is a positive step forward in improving the lives of individuals affected by this debilitating condition,” states an FMI analyst.
Contact Our Market Research Specialist@ https://www.futuremarketinsights.com/ask-question/rep-gb-16801
Competitive Landscape
Key players in the Post-Traumatic Stress Disorder (PTSD) Treatment market are: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, Viatris Inc., Jubilant Pharmova
- Otsuka has also partnered with the US Department of Veterans Affairs (VA) to conduct a clinical trial of a medication called samidorphan (ALKS 5461) for the treatment of PTSD. Samidorphan is an opioid system modulator that is being investigated for its ability to reduce symptoms of PTSD, including anxiety, depression, and hyperarousal.
- Bionomics Limited is a biopharmaceutical company that has developed a medication called BNC210, which is being investigated as a potential treatment for PTSD (Post-Traumatic Stress Disorder). BNC210 is a small molecule drug that acts as a negative allosteric modulator of the α7 nicotinic acetylcholine receptor (α7 nAChR), which is thought to play a role in the development and maintenance of PTSD symptoms.
Key Segments Profiled in the Post-Traumatic Stress Disorder (PTSD) Treatment Industry Survey
By Drug Class:
- Antidepressants
- Anti-anxiety Drugs
- Antipsychotics
- Other Drug Classes
By Distribution Channel:
- Retail Pharmacies
- Online Pharmacies
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/16801
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
